SEARCH

SEARCH BY CITATION

References

  • 1
    Di Bisceglie AM. Hepatitis C. Lancet 1998; 351:351335.MEDLINE
  • 2
    McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, et al. IFN alfa-2 b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:14851492.MEDLINE
  • 3
    Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 1998; 352:14261432.MEDLINE
  • 4
    Reichard O, Norkrans G, Fryden A, Braconier JH, Sonnerborg A, Weiland O. Randomised, double-blind, placebo-controlled trial of interferon alpha- 2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. Lancet 1998; 351:8387.MEDLINE
  • 5
    Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, et al. Interferon alfa-2 b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:14931499.MEDLINE
  • 6
    National Institutes of Health Consensus Development Conference Panel Statement. Management of hepatitis C. Hepatology 1997; 26:2S10S.MEDLINE
  • 7
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177188.MEDLINE
  • 8
    Fleiss JL. Statistical methods for rates and proportions. New York: Wiley, 1981.
  • 9
    Brillanti S, Garson J, Foli M, Whitby K, Deaville R, Masci C, Miglioli M, et al. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 1994; 107:812817.MEDLINE
  • 10
    Schvarcz R, Yun ZB, Sonnerborg A, Weiland O. Combined treatment with interferon alpha-2 b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. J Med Virol 1995; 46:4347.MEDLINE
  • 11
    Pol S, Couzigou P, Bourliere M, Abergel A, Combis J-M, Larrey D, Tran A, et al. A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment. Multicenter study group under the coordination of the Necker Hospital, Paris, France. J Hepatol 1999; 31:17.MEDLINE
  • 12
    Salmeron J, Ruiz-Extremera A, Torres C, Rodriguez-Ramos L, Lavin I, Quintero D, Palacios A. Interferon versus ribavirin plus interferon in chronic hepatitis C previously resistant to interferon: a randomized trial. Liver 1999; 19:275280.MEDLINE
  • 13
    Scotto G, Ferrara S, Mangano A, Conte PE, Tantimonaco G. Treatment with ribavirin + alpha interferon in HCV chronic active hepatitis non-responders to interferon alone: preliminary results. J Chemother 1995; 7:5861.MEDLINE
  • 14
    Scotto G, Fazio V, Tantimonaco G. Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone. Ital J Gastroenterol 1996; 28:505511.MEDLINE
  • 15
    Nyberg L, Albrecht J, Glue P, Gianelli G, Zambas D, Elliot M, Conrad A, et al. Changes in serum hepatitis C virus RNA in interferon nonresponders retreated with interferon plus ribavirin: a preliminary report. J Clin Gastroenterol 1999; 28:313316.MEDLINE
  • 16
    Teuber G, Berg T, Hoffmann RM, Leifeld L, Lafrenz M, Spengler U, Pape GR, et al. Re-treatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C. Digestion 2000; 61:9097.MEDLINE
  • 17
    Andreone P, Cursaro C, Gramenzi A, Fiorino S, Di Giammarino L, Miniero R, D'Errico A, et al. Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study. Ital J Gastroenterol Hepatol 1999; 31:688694.MEDLINE
  • 18
    Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, et al. Interferon-alpha-2 B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study. Am J Gastroenterol 1998; 93:24452451.MEDLINE
  • 19
    Barbaro G, Di Lorenzo G, Belloni G, Ferrari L, Paiano A, Del Poggio P, Bacca D, et al. Interferon alpha-2 B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial. Am J Med 1999; 107:112118.MEDLINE
  • 20
    Bellobuono A, Mondazzi L, Tempini S, Silini E, Vicari F, Ideo G. Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the re-treatment of chronic hepatitis C: a randomized clinical trial. J Viral Hepat 1997; 4:185191.MEDLINE
  • 21
    Brillanti S, Miglioli M, Barbara L. Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience. J Hepatol 1995; 23(Suppl 2):1316.MEDLINE
  • 22
    Sostegni R, Ghisetti V, Pittaluga F, Marchiaro G, Rocca G, Borghesio E, Rizzetto M, et al. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial. Hepatology 1998; 28:341346.MEDLINE
  • 23
    Bell H, Hellum K, Harthug S, Myrvang B, Ritland S, Maeland A, von der Lippe B, et al. Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group. Scand J Gastroenterol 1999; 34:194198.MEDLINE
  • 24
    Andreone P, Gramenzi A, Cursaro C, Sbolli G, Fiorino S, Di Giammarino L, Miniero R, et al. Interferon-alpha plus ribavirin in chronic hepatitis C resistant to previous interferon-alpha course: results of a randomized multicenter trial. J Hepatol 1999; 30:788793.MEDLINE
  • 25
    Milella M, Santantonio T, Pietromatera G, Maselli R, Casalino C, Mariano N, Genchi C, et al. Re-treatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone. Ital J Gastroenterol Hepatol 1999; 31:211215.MEDLINE
  • 26
    Bresci G, Parisi G, Bertoni M, Scatena F, Capria A. Interferon plus ribavirin in chronic hepatitis C non-responders to recombinant alpha-interferon. J Viral Hepat 2000; 7:7578.MEDLINE
  • 27
    Schvarcz R, Ando Y, Sonnerborg A, Weiland O. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience. J Hepatol 1995; 23:1721.MEDLINE
  • 28
    El-Zayadi A, Selim O, El Haddad S, Hamdy H. Combination treatment of alpha interferon-2 b (alpha IFN) and ribavirin in chronic hepatitis C genotype 4 patients resistant to interferon therapy. Hepatology 1995; 22:152A.
  • 29
    Moreno-Monteagudo JA, Fernandez-Bermejo M, Garcia-Buey L, Sanz P, Iacono LO, Garcia-Monzon C, Borque MJ, et al. Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy. Aliment Pharmacol Ther 1998; 12:717723.MEDLINE
  • 30
    Wedemeyer H, Jackel E, Wedemeyer J, Frank H, Schuler A, Trautwein C, Manns MP. [Is combination therapy of chronic hepatitis C with interferon alpha and ribavirin in primary interferon nonresponders indicated?—An analysis of personal experiences and review of the literature]. Z Gastroenterol 1998; 36:819827.MEDLINE
  • 31
    Diago M, Valeros MD, Lujan M, Cors R, Carbonell P, Aznar V, Andreu J, et al. Chronic hepatitis C non responder patients to interferon: results after stopping one year of interferon plus ribavirin combination [abstract]. Hepatology 1998; 28:713A.
  • 32
    Hinrichsen H, Buggisch P, Reiser M, Schmidt WE. High dose interferon alfa-2 a plus ribavirin for the treatment of chronic hepatitis C: preliminary results of a multicenter trial [abstract]. Hepatology 1998; 28:716A.
  • 33
    Siciliano R, Russello M, Rosso D, Rapisarda S, Elia G, Benigno R, Santangelo N, et al. Ribavirin + alpha-IFN in patients with chronic hepatitis C—genotype 1b non responder to alpha-IFN [abstract]. Hepatology 1998; 28:715A.
  • 34
    Di Marco V, Vaccaro A, Ferraro D, Lo Iacono O, Parisi P, Di Stefano R, Almasio P, et al. Dynamic of response to IFN plus ribavirin in relapsers and non responders with chronic hepatitis C [abstract]. Hepatology 1998; 28:714A.
  • 35
    Everson GT, Folan R, Goff J, Richman L, Anselm C, Trouillot T, Shrestha R, et al. The Colorado hepatitis treatment group: early results of the use of combination interferon-alfa-2 b (Intron-A) plus ribavirin (Rebetol) in the treatment of nonresponders [abstract]. Hepatology 1998; 28:476A.
  • 36
    Lewis JH, Gallagher JE, Epstein MS, Gibbs L, Howell CD. Interim results of the Washington, DC metropolitan area study of IFN alfa-2 b (Intron A) plus ribavirin (RIBA) for prior non-responders (NR) and relapsers (RLP) with chronic hepatitis C [abstract]. Hepatology 1998; 28:289A.
  • 37
    Sjogren MH, Holtzmuller K, Kadakia S, Lawitz E, Sjogren R, Loughney T, Deguide J. High response rate to interferon/ribavirin (INF/RIB) treatment in HCV relapsers but not in non-responders [abstract]. Hepatology 1998; 28:287A.
  • 38
    Kullig U, Porst H, Herrmann A, Wiese M, Schmidt U, Sundermann U. Interferon plus ribavirin re-treatment in patients with chronic hepatitis C [abstract]. Hepatology 1998; 28:207A.
  • 39
    Pinar A, Salas E, Carmona I, Rojas M, Rebollo J, Gonzalez-Vilchez J, Jimenez-Saenz M, et al. High rate of complete response to combination therapy in patients with chronic hepatitis C (CHC) refractory to interferon alfa [abstract]. Hepatology 1998; 28:286A.
  • 40
    Herrera J. Combination therapy with interferon and ribavirin for chronic hepatitis C patients resistant to alfa interferon [abstract]. Hepatology 1998; 28:375A.
  • 41
    Anderson FH, Rock NR, Sherlock C. Long term interferon and ribavirin combination therapy in chronic hepatitis C patients unresponsive to interferon monotherapy [abstract]. Hepatology 1998; 28:716A.
  • 42
    Perasso A, Testino G, Ansaldi F, Venturino V, Icardi GC. r-Interferon alfa-2 b/ribavirin combined therapy followed by low-dose r-interferon alfa-2 b in chronic hepatitis C interferon nonresponders [letter]. Hepatology 1999; 29:297298.MEDLINE
  • 43
    Frider B, Findor JA, Perez V, Terg R, Tanno H, Villamil F, Faimboim H, et al. Response to 12-month treatment with interferon alfa-2 B (INF a-2 B) plus ribavirin in patients with chronic hepatitis C relapsers or non responders to a previous INF treatment [abstract]. Hepatology 1999; 30:196A.
  • 44
    Kwo PY, Pound DC, Fields S, Glowinski EA, Chalasani N, Cho WK, Crabb DW, et al. Alpha-interferon plus ribavirin for the treatment of chronic hepatitis C in patients who have failed treatment with alpha-interferon [abstract]. Hepatology 1999; 30:368A.
  • 45
    Puoti M, Civili AOS, Costa P, Alessi F, Morandini B, Re T, Putzolu V, et al. High dose interferon + ribavirin combination re-treatment is cost-effective in patients with HCV genotype other than 1 who failed to respond to interferon monotherapy [abstract]. Hepatology 1999; 30:628A.
  • 46
    Kallinowski B, Liehr H, Moeller B, Stremmel W, Wechsler J, Weise M, Goeser T. Combination therapy with interferon-alfa2B and ribavirin for the treatment of nonresponder and relapse patients with chronic hepatitis C: a multicentre study [abstract]. Hepatology 1999; 30:263A.
  • 47
    Srinivasan R, Bromer MQ, Burke M, Shah R, Ma X, Chung CY. Response rates to combination therapy in previously treated hepatitis C patients, both relapsers and nonresponders, in an urban tertiary care center—interim results [abstract]. Hepatology 1999; 30:370A.
  • 48
    Box TD, Boschert ME, Bowers JH, Hutson WR, Thomason IR, Christiansen JE, Rose K, et al. The significance of HCV RNA “breakthrough” in Rebetron therapy. Hepatology 1999; 30:271A.
  • 49
    Labrecque DR, Phillips MJP, Hershberger JM, Swift JM, Schrock DM, Ippolito LA, Juhl RD, et al. Rebatron therapy of chronic hepatitis C patients who were non-responsive or relapsed on interferon monotherapy [abstract]. Hepatology 1999; 30:267A.
  • 50
    Talwalkar J, Lalan S, Hauser S, Grace N, Reid AE, Corasanti J, Fiarman G, et al. Combination therapy with interferon-alfa-2 B (Intron-A) and ribavirin (Rebetol) in chronic hepatitis C patients previously relapsing or not responding to interferon alone [abstract]. Hepatology 1999; 30:197A.
  • 51
    Monsour HP, Mailliard M, Clark JH, Galler GW, Abou-Awdi NL, Vallejo BC, Galati JS, et al. Interim analysis of a multi-center trial of ribavirin plus interferon (INF) alfa 2B in patients with chronic hepatitis C previously treated with interferon only [abstract]. Hepatology 1999; 30:197A.
  • 52
    Naylor PH, Brown KA, Gordon SC, Moonka D, Silverman AL, Kinzie JL, Ehrinipreis MN, et al. Response to re-treatment with interferon/ribavirin in Caucasian and African American relapsers and nonresponders [abstract]. Hepatology 1999; 30:373A.
  • 53
    Krawitt EL, Albertini R, John A, Gordon S, Cimis R, Maheshwari Y, Kaplan M, et al. Interim results of the NYNEST interferon-ribavirin re-treatment trial in chronic hepatitis C non-responders [abstract]. Hepatology 1998; 28:375A.
  • 54
    Min AD, Jones JL, Lebovics E, Jacobson IM, Klion FM, Goldman IS, Esposito S, et al. Interferon alfa-2 b and ribavirin in patients with resistant chronic hepatitis C [abstract]. Hepatology 1999; 30:192A.
  • 55
    Bacon BR, Rauscher JA, Smith-Wilkaitis NL, Koehler KM, Antal MJ. Interferon-ribavirin combination: sustained response in previous monotherapy non-responders [abstract]. Hepatology 1999; 30:372A.
  • 56
    Herrine SK, Conn MI, Greenfield SM, Shaw EW, Thornton JJ, Weinberg DS. Interferon alpha-2 B and ribavirin for interferon monotherapy non-responders [abstract]. Hepatology 1999; 30:370A.
  • 57
    Dettmer R, Aytaman A, Bloom AA, Clain DJ, Magun A, Meyer D, Levendoglu H, et al. Multicenter, placebo-controlled, double-blind trial of interferon alpha-2 B plus ribavirin vs. interferon alone for re-treatment of non-responders and relapsers with chronic hepatitis C who have failed previous treatment with interferon: a 48 week review [abstract]. Hepatology 1999; 30:201A.
  • 58
    Hassanein TI, Monson P, Behling C, Chatfield ER, Aronson N, Chen P, Medley K, et al. In HCV non-responders: combination therapy is more effective than induction therapy in achieving viral clearance [abstract]. Hepatology 1999; 30:626A.
  • 59
    Malik AH, Malet PF, Harford W, Wood M, Yarbrough K, Lee WM. HCV nonresponders: standard combination therapy versus an induction regimen of high dose interferon alfa-2 B (IFN) with ribavirin (RIB) [abstract]. Hepatology 1999; 30:633A.
  • 60
    Picciotto A, Torre F, Campo N, Giusto R, Brizzolara R, Sinelli N, Giudici-Cipriani A, et al. Interferon plus ribavirin (6 vs 12 months) in chronic hepatitis C patients non responders to interferon alone [abstract]. Hepatology 1999; 30:263A.
  • 61
    Ascione A, De Luca M, Guardascione MA, Canestrini C, Galeota Lanza A, Astritto S, D'Asero C, et al. Interferon plus ribavirin vs interferon alone in HCV chronic liver disease non responder to a previous cycle of interferon alone [abstract]. J Hepatol 1998; 28(Suppl 1):198.
  • 62
    Brillanti S, Foli M, Di Tomaso M, Gramantieri L, Masci C, Bolondi L. Response to triple antiviral therapy in interferon non-responders with chronic hepatitis C [abstract]. J Hepatol 1998; 28(Suppl 1):114.
  • 63
    De Bac C, Pastore G, Piccinino F, Badolato MC, Tosti ME, Osso A, Milella M, et al. Ribavirin and interferon re-treatment of HCV chronic patients non responder to interferon [abstract]. J Hepatol 1998; 28(Suppl 1):123.
  • 64
    Chemello L, Cavalletto L, Bernardinello E, Donada C, Belussi F, Casarin P, Urban F, et al. Re-treatment of chronic hepatitis C (CHC) with sequential interferon-ribavirin combination (IFN-RIBA) therapy [abstract]. J Hepatol 1998; 28(Suppl 1):109.
  • 65
    Tripi S, Di Gaetano G, Cartabellotta F, Vassallo R, Soresi M, Carroccio A, Savi A, et al. Ribavirin and alpha-interferon in patients with chronic hepatitis C not responding to interferon alone [abstract]. J Hepatol 1998; 28(Suppl 1):212.MEDLINE
  • 66
    Vucelic B, Ostojic R, Hrstic I, Scukanec-Spoljar M, Vince A. Re-treatment of chronic hepatitis C with ribavirin and interferon alpha: a study in non-responding and relapsing group of patients [abstract]. J Hepatol 1998; 28(Suppl 1):197.
  • 67
    Marchi S, Ciccorossi P, Petruccelli S, Ricchiuti A, Arpe P, Da Massa Carrara P, Costa F, et al. Can interferon-ribavirin effectively treat patients who did not respond to a first conventional therapy by interferon? [abstract]. J Hepatol 1998; 28(Suppl 1):121.
  • 68
    Grimaldi F, Chircu LV, De Sanctis GM, Altavilla N, Diaco MC, Guadagnino E. Ribavirin plus alfaIFN in the treatment of non-responder or relapser patients with chronic hepatitis C [abstract]. J Hepatol 1999; 30(Suppl 1):255.
  • 69
    Karatapanis S, Keticoglou I, Georgopoulos S, Karatapanis S, Giannakidis S, Vaina S, Papamarkos D, et al. Efficacy of interferon (IFN) in combination with ribavirin in chronic hepatitis C patients not responding or relapsing to IFN alone [abstract]. J Hepatol 1999; 30(Suppl 1):253.
  • 70
    Olaso V, Lopez B, Cordoba J, Prieto M, Urquijo JJ, Siles MS, Arguello L, et al. Therapeutic efficacy of interferon + ribavirin (IFN+R), 6 vs. 12 months, in chronic hepatitis C (CH-C) patients who were non-responders (NR) or relapsers (RR) to a previous treatment with interferon [abstract]. J Hepatol 1999; 30(Suppl 1):136.
  • 71
    Sapper U, Hermann R, Schwinn A, Maier KP. Therapy of hepatitis C in interferon non-responders. Results of a pilot study comparing interferon vs. interferon/ribavirin after iron depletion [abstract]. J Hepatol 1997; 26(Suppl 1):200.
  • 72
    Vega P, Castro A, Hermida M, Lopez S, Balinas J, Pedreira JD. Interferon plus ribavirin re-treatment during 12 months in patients with chronic hepatitis C [abstract]. J Hepatol 1999; 30(Suppl 1):236.
  • 73
    Longo MA, Boumis E, Palmieri F, Noto P, Struglia C, Capecchi A, Zechini F, et al. Alpha interferon 2b plus ribavirin in interferon non-responders or relapsing chronic hepatitis C patients [abstract]. J Hepatol 1999; 30(Suppl 1):240.
  • 74
    Zorat F, Mazzoran L, Gregorutti M, Nascimben F, Baracetti S, Pozzato G. Re-treatment with interferon plus ribavirin in patients affected by chronic hepatitis C [abstract]. J Hepatol 1999; 30(Suppl 1):244.
  • 75
    Moscarella S, Buzzelli G, Romanelli RG, Arena U, Careccia G, Giannelli F, Marrocchi ME, et al. Interferon-alfa (IFNalfa) + Ribavirin (RIBA) therapy for chronic hepatitis C (CHC) patients, non responders (NRs) to IFNalfa monotherapy [abstract]. J Hepatol 1999; 30(Suppl 1):248.
  • 76
    Nunes DP, Anastopoulos H, Gordon F, Chopra S, Petruff C, Salomons H, Wilson S, et al. Double-blind placebo controlled study of interferon versus interferon plus ribavirin for the treatment of hepatitis C in patients who previously failed interferon monotherapy [abstract]. Hepatology 1999; 30:199A.
  • 77
    Morisco F, Canestrini C, Astretto S, Iasevoli P, Caporaso N, Ascione A. Therapeutic efficacy of reinforced vs. standard combination therapy schedule (IFN alfa2B + ribavirin) in chronic hepatitis C patients not responding or relapsing to IFN alone [abstract]. Hepatology 1999; 30:198A.
  • 78
    Ferenci P, Stauber R, Steindl-Munda P, Gschwantler M, Fickert P, Datz C, Muller C, et al. Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon-alpha in interferon nonresponders with chronic hepatitis C. J Viral Hepat 1999; 6:5358.MEDLINE
  • 79
    Andreone P, Cursaro C, Gramenzi A, Margotti M, Ferri E, Talarico S, Di Giammarino L, et al. High dose of interferon α (IFN) plus ribavirin (RIBA) for 6 or 12 months in non repsonder (NR) patients with chronic hepatitis C (CHC): results of a randomized trial [abstract]. European Association for the Study of the Liver Conference 2000. Available at http://journals.munksgaard.dk/easl/html/hep088.htm (accessed 4/27/00).
  • 80
    Salmeron J, Martin Vivaldi R, De la Mata M, Romero M, Perez Moreno J, Aguilar J, Palacios A, et al. Interferon alfa plus ribavirin in chronic hepatitis C relapsers and non-responders to previous interferon alfa course [abstract]. European Association for the Study of the Liver Conference 2000. Available at http://journals.munksgaard.dk/easl/html/hep746.htm (accessed 4/27/00).
  • 81
    Vandellli C, Renzo F, Vecchi C, Lovato E, Tisminetzky S, Ventura E. Re-treatment of chronic hepatitis C patients with interferon plus ribavirin vs interferon alone [abstract]. European Association for the Study of the Liver Conference 2000. Available at http://journals.munksgaard.dk/easl/html/hep300.htm (accessed 4/27/00).
  • 82
    Steindl-Munda PJ, Kopty DC, Ferenci P, Vogel W, Datz C, Brunner H, Stauber R. Re-treatment of IFN nonresponders (NR) or relapsers (REL) with chronic hepatitis C with high dose interferon (IFN) in combination with ribavirin [abstract]. European Association for the Study of the Liver Conference 2000. Available at http://journals.munksgaard.dk/easl/html/hep054.htm (accessed 4/27/00).
  • 83
    Buti M, Olive G, Stalgis C, Esteban R, Guardi J. Quantification of serum hepatitis C virus RNA with daily or standard interferon doses plus ribavirin in nonresponder patients with chronic hepatitis C. Dig Dis Sci 2000; 45:685689.MEDLINE
  • 84
    Khalili M, Denham C, Perrillo R. Interferon and ribavirin versus interferon and amantadine in interferon. Am J Gastroenterol 2000; 95:12841289.MEDLINE
    Direct Link:
  • 85
    Lo Iacono O, Castro A, Diago M, Moreno JA, Fernandez-Bermejo M, Vega P, Garcia V, et al. Interferon alfa-2 b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy. Aliment Pharmacol Ther 2000; 14:463469.MEDLINE
  • 86
    Tromm A, Greving I, Griga T, Mankel K, Huppe D. Interferon-alpha-2 b + ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-alpha-monotherapy. Zeitschrift fur Gastroenterologie 2000; 38:159164.MEDLINE
  • 87
    Bellobuono A, Tempini S, Grimoldi D, Ideo GM, Mondazzi L, Brasca P, Ideo G. Effect of 12 month alfa-IFN and ribavirin combination therapy in chronic hepatitis C unresponsive to alfa-IFN. European Association for the Study of the Liver Conference 2000. Available at http://journals.munksgaard.dk/easl/html/hep020.htm (accessed 4/27/00).
  • 88
    Shiffman ML, Hofmann CM, Gabbay J, Luketic VA, Sterling RK, Sanyal AJ, Contos MJ, et al. Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. Am J Gastroenterol 2000; 95:29282935.MEDLINE
    Direct Link:
  • 89
    Davis GL, Lau JYN. Factors predictive of a beneficial response to therapy of Hepatitis C. Hepatology 1997; 26(Suppl 1):122S127S.MEDLINE
  • 90
    Fleiss JL, Gross AJ. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique. J Clin Epidemiol 1991; 44:127139.MEDLINE